Abstract:OBJECTIVE:To study the clinical features of primary biliary cirrhosis (PBC) in order to facilitate cognition of the disease.METHODS:Clinical data of 42 patients clinically and/or histologically diagnosed with PBC were reviewed. Anti mitochondrial antibody (AMA) negative/positive patients as well as the patients who were/were not associated with Sjogren Syndrome (SS) were compared in terms of clinical, biochemical and immunological features.RESULTS:Among the 42 patients, 78.6% (33/42) of the cases were females; the mean age at diagnosis was (61.1+/-10.8) years. The most frequent symptoms were fatigue. Serum alkaline phosphatase (ALP), gamma-glutamyltranspeptidase (gamma-GT) and total bile acid (TBA) levels were markedly elevated in the majority of the patients, whereas ALT and AST levels were mildly to moderately elevated. Thirty-one patients had a total bilirubin (TBil) level above normal. The levels of TBil and prothrombin time had positive correlationship with years of the course (P=0.000, r=0.696; P=0.005, r=0.424), whereas serum albumin level had negative correlationship with years of the course (P=0.002, r=-0.462). Thirty-seven patients had elevated serum IgM and 34 patients were AMA/AMA-M(2) positive. AMA negative and AMA positive patients were similar in terms of clinical manifestations and liver biochemistries findings. Serum IgM and IgA levels were significantly lower, whereas total cholesterol level was higher in AMA negative patients when compared with AMA positive cases. Fifteen cases were associated with SS, which were similar in terms of clinical, biochemical and immunological features when compared with the PBC patients were not associated with SS.CONCLUSION:PBC is mostly found in middle aged and old women. Elevated serum ALP, TBA and gamma-GT levels together with positive AMA/AMA-M(2) can help to diagnose PBC. AMA negative PBC patients are characterized by relatively lower serum IgM and IgA levels and higher total cholesterol level. PBC patients who are associated with SS have not substantial differences in the clinical, biochemical and immunological spectra of the disease.

Primary biliary cirrhosis:an analysis of 76 cases

Clinical Analysis of Primary Biliary Cirrhosis: a Report of 31 Cases

[Clinical and Pathological Characteristics of Primary Biliary Cirrhosis].

[Clinical Analysis of Primary Biliary Cirrhosis: a Report of 42 Cases].

Clinical characteristics of patients with primary biliary cirrhosis

Clinical Characteristics of Primary Biliary Cirrhosis: a Retrospective Analysis of 101 Cases

[Primary biliary cholangitis. Experience in 179 patients]

Primary biliary cirrhosis,3 cases of clinical analysis

Retrospective study and meta-analysis:the clinical features of patients with primary biliary cirrhosis in recent 20 years in China

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

A Serum Metabolomic Analysis for Diagnosis and Biomarker Discovery of Primary Biliary Cirrhosis and Autoimmune Hepatitis.

Insight into the natural history of primary biliary cirrhosis: A systemic review of data from placebo-controlled clinical trials.

Clinical and pathological characters of AMA-M2 negetive primary biliary cirrhosis

Laboratory analysis of 361 PBC patients with AMA-M2 positive

Clinical and Pathology Analysis of Patients with Primary Biliary Cirrhosis

A case of primary biliary cholangitis – diagnostic and treatment approaches

S2711 Primary Biliary Cholangitis: A Peculiar Presentation

Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Diagnosis and Treatment of Primary Biliary Cirrhosis-Autoimmune Hepatitis Overlapping Syndrome:An Analysis of 30 Cases

Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis

Clinical and Pathological Analysis of Primary Biliary Cirrhosis-Autoimmune Hepatitis Overlap Syndrome